
CEOs often claim that mega-mergers yield operational efficiencies--but the argument is usually bogus. In most cases, potential efficiency gains are swamped by the costs of integration and the increased bureaucracy that comes with a larger and more complex organization. The real advantages of a mega-scale firm are unmatched political clout and greater pricing power. These gains come at the expense of consumers and citizens. That's why I support the recently introduced bipartisan Bill to Break Up Big Medicine. thebignewsletter.com/p/senators-see…
English








